These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6372653)

  • 21. Platelet and plasma serotonin in glomerulonephritis. III: The nephritis of systemic lupus erythematosus.
    Parbtani A; Frampton G; Yewdall V; Kasai N; Cameron JS
    Clin Nephrol; 1980 Oct; 14(4):164-72. PubMed ID: 7428190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Platelet aggregation and the fibronectin level of the blood in children with chronic glomerulonephritis].
    Pinelis VG; Razdol'kina TI; Sergeeva TV; Gozalishvili TV; Storozhevykh TP; Tsygin AN
    Urol Nefrol (Mosk); 1995; (4):17-9. PubMed ID: 7571193
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of platelets in glomerulonephritis.
    Cameron JS
    Nihon Jinzo Gakkai Shi; 1983 Jul; 25(7):786-97. PubMed ID: 6663841
    [No Abstract]   [Full Text] [Related]  

  • 24. [Platelet mediators of vascular permeability and phlogosis].
    Camussi G; Masera C; Deregibus MC; Bussolino F; Tetta C; Emanuelli G; Calcamuggi G; Stratta P; Viglino GL
    Minerva Nefrol; 1980; 27(2):301-4. PubMed ID: 7219852
    [No Abstract]   [Full Text] [Related]  

  • 25. The influence of selective thrombocytopenia on nephrotoxic nephritis.
    Lavelle KJ; Ransdell BA; Kleit SA
    J Lab Clin Med; 1976 Jun; 87(6):967-75. PubMed ID: 1084380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spontaneous chemotaxis in patients with glomerulonephritis and the nephrotic syndrome.
    Norman ME; Miller ME
    J Pediatr; 1973 Sep; 83(3):390-8. PubMed ID: 4725144
    [No Abstract]   [Full Text] [Related]  

  • 27. Role of platelets in glomerulonephritis.
    Hayslett JP
    N Engl J Med; 1984 May; 310(22):1457-8. PubMed ID: 6717525
    [No Abstract]   [Full Text] [Related]  

  • 28. Basic and translational concepts of immune-mediated glomerular diseases.
    Couser WG
    J Am Soc Nephrol; 2012 Mar; 23(3):381-99. PubMed ID: 22282593
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of dipyridamol on the electrokinetic potential of platelets.
    Aznar J; Vallés J
    Rev Esp Fisiol; 1974 Jun; 30(2):77-9. PubMed ID: 4278529
    [No Abstract]   [Full Text] [Related]  

  • 30. Aspirin and dipyridamole inhibition of collagen-induced platelet aggregation and release in cynomolgus monkeys.
    Wang ZG; McCann RL; Hagen PO
    Chin Med J (Engl); 1984 Jan; 97(1):19-23. PubMed ID: 6428828
    [No Abstract]   [Full Text] [Related]  

  • 31. Platelet-aggregating immune complexes and intraplatelet serotonin in idiopathic glomerulonephritis and systemic lupus.
    Kasai N; Parbtani A; Cameron JS; Yewdall V; Shepherd P; Verroust P
    Clin Exp Immunol; 1981 Jan; 43(1):64-72. PubMed ID: 7249395
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The platelet as a mediator of tissue damage in immune complex glomerulonephritis.
    Clark WF; Friesen M; Linton AL; Lindsay RM
    Clin Nephrol; 1976 Jul; 6(1):287-9. PubMed ID: 133779
    [No Abstract]   [Full Text] [Related]  

  • 33. [The efficacy of kurantil and its effect on thrombocytic hemostasis in patients with chronic glomerulonephritis].
    Kolesnyk MO; Lapchyns'ka II; Bielyts'ka HO
    Lik Sprava; 1994; (9-12):145-8. PubMed ID: 7604556
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pathogenesis of immune glomerulonephritis].
    Rougier JP; Ronco P
    Rev Prat; 2003 Nov; 53(18):1998-2004. PubMed ID: 15008213
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Evaluation of factors influencing platelet aggregation in patients with chronic glomerulonephritis (CGN)].
    Zdrojewski Z; Raszeja-Specht A; Kustosz J; Skibowska A; Rutkowski B
    Przegl Lek; 1996; 53(5):434-8. PubMed ID: 8754409
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Ristocetin induced platelet aggregation in children with nephrotic syndrome].
    Taira K; Okajima C; Yamashita T; Kawahara S; Matsunaga T; Nakajima M; Kamitsuji H
    Nihon Jinzo Gakkai Shi; 1990 Jun; 32(6):659-66. PubMed ID: 2214316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comprehensive study on platelet function, hemostasis, fibrinolysis, peripheral serotonergic system and serum lipids in nephrotic syndrome.
    Małyszko J; Małyszko JS; Pawlak D; Pawlak K; Rydzewski A; Myśliwiec M; Buczko W
    Pol J Pharmacol; 1996; 48(2):191-5. PubMed ID: 9112650
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative assessment of the effects of platelet depletion in the autologous phase of nephrotoxic serum nephritis.
    Sindrey M; Marshall TL; Naish P
    Clin Exp Immunol; 1979 Apr; 36(1):90-6. PubMed ID: 157239
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Focal mesangial proliferative glomerulonephritis in the rat caused by Habu venom: the effect of antiplatelet agents.
    Cattell V; Mehotra A
    Br J Exp Pathol; 1980 Jun; 61(3):310-4. PubMed ID: 7000132
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Platelets and the inflammatory response.
    Weksler BB
    Clin Lab Med; 1983 Dec; 3(4):667-76. PubMed ID: 6360503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.